Lacktman Quoted on Telemedicine and Restrictive State Laws
November 3, 2016
Bloomberg BNA Health Law Reporter
Partner Nathaniel Lacktman was quoted in a Bloomberg BNA Health Law Reporter article, “Online Eye-Test Company Sues State, Says Licensing Law Violates S.C. Constitution,” on November 3, 2016. The article discussed telemedicine provider Opternative’s challenge against a South Carolina law that forbids the use of automated eye tests for renewing corrective lens prescriptions.
Lacktman said the suit is another example in a wave of telehealth providers pushing back against restrictive state laws and rules. He was quoted saying, “I respect the efforts of telehealth companies like Opternative to continue to advocate for patient’s rights to enjoy convenient, accessible healthcare. Ideally, state laws and regulations should strike the right balance between ensuring patient safety and promoting innovation and efficiencies in the way healthcare is delivered.”
Lacktman said the suit is another example in a wave of telehealth providers pushing back against restrictive state laws and rules. He was quoted saying, “I respect the efforts of telehealth companies like Opternative to continue to advocate for patient’s rights to enjoy convenient, accessible healthcare. Ideally, state laws and regulations should strike the right balance between ensuring patient safety and promoting innovation and efficiencies in the way healthcare is delivered.”
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."